Orgenesis - נכסים נקיים למניה בודדת ORGS
Demand for personalized medicine from Orgenesis Inc. is driven by biological necessity, rendering the business independent of economic cycles. However, the complexity of live cell logistics and regulatory barriers create operational risks. Growth relies on the integration of POCare digital modules into clinical processes. The book value per share trend reflects net assets, where the -3.31 level represents the current value.
orgenesis.com - פילוחים אנליטיים ומדדי מפתח (ORGS)
Book value per share reflects the issuer's net assets, calculated as the difference between total assets and all liabilities, divided by the number of securities. Analyzing equity per share allows for an assessment of the intrinsic stability of Orgenesis Inc. (ORGS) amid the absence of stable cash flows from the Inertia platform and high operating expenses required to support the business.